According to a new market research report by iData Research, the leading international authority in medical device, dental and pharmaceutical market research, the US market for spinal motion preservation devices is estimated to reach $2.54 billion by 2015.
The global market for minimally invasive surgery (MIS) is also estimated to see double digit growth, with these two segments driving the overall market for spinal implants, MIS and VCF devices.
Spinal fusion prepares two adjacent vertebral bodies to fuse together, forming one fused bone. This is the standard for surgical treatment of back pain. Motion preservation devices are used to treat pathologies traditionally treated by spinal fusion, however unlike fusion; motion preservation devices act to preserve the natural motion of the spine. Motion preservation devices also treat pathologies that historically were not treated by implants, expanding the spinal implant market.
“Motion preservation technologies are believed to revolutionize spinal surgery,” says Kamran Zamanian, President and CEO of iData Research. “The market is expected to continue experiencing tremendous growth globally, slowly cannibalising spinal fusion procedures.”
Minimally invasive surgery (MIS) for spinal fusion, a sub-segment of the spinal fusion market, consists of devices and procedures associated with a less invasive approach to performing spinal fusion. Posterior screw/rod and interbody devices are implanted with minimal surgical damage to the patient, leading to quicker recovery times. The number of MIS procedures is estimated to grow at a CAGR of 18% through 2015, with companies such as Medtronic, Nuvasive and Depuy leading the market.
“The US spinal fusion implant market was valued at over $3.7 billion in 2008, with the MIS market representing a significant portion of that value,” says Zamanian.